IPO registrations (S-1, F-1) · Registrants
Cocrystal Pharma, Inc.
- SEC CIK
- 1412486 · filings on EDGAR ↗
- Former names
- BIOZONE PHARMACEUTICALS, INC. (2011–2014); International Surf Resorts, Inc. (2007–2011)
- Registration
- Form S-1, first filed 2011-09-21, last 2025-09-19; 2 initial registrations, 8 amendments
- Outcome
- Declared effective 2013-02-14; withdrawal requested 2016-07-15
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 19805 N. CREEK PARKWAY, Bothell, WA 98011
- EIN
- 35-2528215
- Ticker
- COCP (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Cocrystal Pharma, Inc. on the corporate pages
Offering terms
- Shares offered
- 5,736,773
- Listing
- Nasdaq under the symbol COCP
- Lead underwriters
- of Contents
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: COCRYSTAL PHARMA, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: COCRYSTAL PHARMA, INC EXACT (EIN (EXACT))
- Federal award recipient: COCRYSTAL PHARMA, INC. Fuzzy (name and state)
- Form D issuer: Cocrystal Pharma, Inc. EXACT (CIK (EXACT))
- SEC filer: BIOZONE PHARMACEUTICALS, INC. EXACT (CIK (EXACT))
- Person page: Jeffrey A Meckler Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
- Person page: Richard C Pfenniger Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-09-21 | S-1 | S-1 (registration) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-11-000266 ↗ |
| 2011-12-19 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-11-000534 ↗ |
| 2012-07-02 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-12-000608 ↗ |
| 2012-09-28 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-12-000983 ↗ |
| 2012-11-29 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-12-001212 ↗ |
| 2013-01-14 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-13-000023 ↗ |
| 2013-01-31 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-13-000075 ↗ |
| 2013-02-08 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-13-000100 ↗ |
| 2013-02-13 | S-1/A | S-1/A (amendment) | BIOZONE PHARMACEUTICALS, INC. | 0001521536-13-000139 ↗ |
| 2013-02-14 | EFFECT | EFFECT (declared effective) | BIOZONE PHARMACEUTICALS, INC. | 9999999995-13-000500 ↗ |
| 2016-07-15 | RW | RW (withdrawal request) | Cocrystal Pharma, Inc. | 0001415889-16-006502 ↗ |
| 2017-10-10 | EFFECT | EFFECT (declared effective) | Cocrystal Pharma, Inc. | 9999999995-17-002628 ↗ |
| 2019-05-22 | EFFECT | EFFECT (declared effective) | Cocrystal Pharma, Inc. | 9999999995-19-001178 ↗ |
| 2020-05-13 | EFFECT | EFFECT (declared effective) | Cocrystal Pharma, Inc. | 9999999995-20-001143 ↗ |
| 2023-05-26 | EFFECT | EFFECT (declared effective) | Cocrystal Pharma, Inc. | 9999999995-23-001555 ↗ |
| 2025-09-19 | S-1 | S-1 (registration) | Cocrystal Pharma, Inc. | 0001493152-25-014266 ↗ |
| 2025-09-25 | EFFECT | EFFECT (declared effective) | Cocrystal Pharma, Inc. | 9999999995-25-003102 ↗ |
| 2026-05-01 | EFFECT | EFFECT (declared effective) | Cocrystal Pharma, Inc. | 9999999995-26-001445 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | S-1 | registration statement | $1.70 | 5,736,773 | $9,752,514 | Nasdaq COCP | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Frost Gamma Investments Trust | Other; TenPercentOwner | 8 | 2014–2023 | ||
| FROST PHILLIP MD ET AL | Director; Director,TenPercentOwner | 26 | 2014–2026 | ||
| HSIAO JANE PH D | Director | 6 | 2014–2018 | ||
| Kornberg Roger D. | Director | 8 | 2014–2026 | ||
| Lee Sam | Director,Officer; Officer | President; PRESIDENT; President and Co-CEO; President and Co-Interim CEO | 11 | 2014–2026 | |
| McGuire Gerald A | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 2 | 2014–2015 | |
| Opko Health, Inc. | TenPercentOwner | 1 | 2014 | ||
| Rubin Steven D | Director | 13 | 2014–2026 | ||
| WILCOX GARY | Director; Director,Officer; Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER; Interim CEO; INTERIM CEO | 7 | 2014–2020 | |
| BLOCK DAVID S | Director | 6 | 2014–2018 | ||
| Meckler Jeffrey A | Director; Director,Officer | CHIEF EXECUTIVE OFFICER | 7 | 2014–2016 | person page Fuzzy |
| Schinazi Raymond F | Director; Director,TenPercentOwner; TenPercentOwner | 15 | 2014–2021 | ||
| Linscott Walt Addison | Officer | GENERAL COUNSEL AND SECRETARY | 2 | 2015 | |
| Mayers Douglas L | Officer | CHIEF MEDICAL OFFICER | 2 | 2015 | |
| Dale Curtis | Officer | INTERIM CFO | 2 | 2015 | |
| Martin James Joseph | Officer | Chief Financial Officer; Co-CEO and CFO; Co- Interim CEO and CFO; Interim CFO | 9 | 2017–2026 | |
| Brady Todd R. | Director | 1 | 2019 | ||
| Japour Anthony J | Director | 7 | 2019–2026 | ||
| PFENNIGER RICHARD C JR | Director | 8 | 2021–2026 | person page Fuzzy | |
| Hassan Fred | Director | 5 | 2023–2026 | ||
| SAPIRSTEIN JAMES | Officer | Chief Executive Officer | 2 | 2026 | |
| Brosgart Carol L | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-05-02 | Cocrystal Pharma, Inc. | Pharmaceuticals | $3,000,000 | $3,000,000 | 3 | 1 |
| 2016-09-15 | Cocrystal Pharma, Inc. | Pharmaceuticals | $4,008,201 | $4,008,201 | 4 | 1 |
| 2016-03-30 | Cocrystal Pharma, Inc. | Pharmaceuticals | $5,004,370 | $5,004,370 | 12 | 1 |
| 2014-01-31 | BIOZONE PHARMACEUTICALS, INC. | Biotechnology | $2,750,000 | $2,750,000 | 8 | 1 |
| 2014-01-17 | BIOZONE PHARMACEUTICALS, INC. | Biotechnology | $0 | $0 | 23 | 1 |
| 2012-03-20 | BIOZONE PHARMACEUTICALS, INC. | Pharmaceuticals | $1,000,000 | $1,000,000 | 1 | 1 |
| 2012-03-09 | BIOZONE PHARMACEUTICALS, INC. | Pharmaceuticals | $2,300,000 | $2,300,000 | 3 | 1 |
| 2012-01-26 | BIOZONE PHARMACEUTICALS, INC. | Pharmaceuticals | $650,000 | $650,000 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | COCRYSTAL PHARMA, INC. | WA | State business registries | name and state |
| Plan sponsor | COCRYSTAL PHARMA, INC | GA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | COCRYSTAL PHARMA, INC. | WA | Federal spending (USAspending) | name and state |
| Form D issuer | Cocrystal Pharma, Inc. | GA | Form D private offerings | CIK (EXACT) |
| Patent assignee | COCRYSTAL PHARMA, INC. | WA | Patents (USPTO) | name and state |
| SEC filer | Cocrystal Pharma, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | COCRYSTAL PHARMA, INC | EIN (EXACT) | ||
| Person page | Jeffrey A Meckler | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) | |
| Person page | Richard C Pfenniger Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, WA first:
- PATHOGENESIS CORP WA
- DENDREON CORP WA
- CORUS PHARMA INC WA
- CytoDyn Inc. WA
- OMEROS CORP WA
- Trubion Pharmaceuticals, Inc WA
- Light Sciences Oncology Inc WA
- ALDER BIOPHARMACEUTICALS INC WA
- PHASERX, INC. WA
- CHINOOK THERAPEUTICS, INC. WA
In other datasets, the same topic (Health) in WA:
- Nonprofit: ACUPUNCTURE RELIEF PROJECT (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health